For instance, Zhou et al. showed that gain-of-function (GOF) mutations in NLRP3 (e.g., R779C) that were identified in very early-onset IBD (VEOIBD) enhanced NLRP3 deubiquitination. The gene discussed is NLRP3; the disease is inflammatory bowel disease.